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Abstract: Adaptation of the whole microbial normal flora residing in a host to its natural habitat over an evolutionary 
peroid has resulted in peaceful coexistence with mutual benefits for both microbiota and host in steady state. This 
symbiotic relationship between host and microbiota has a significant impact on shaping the immune response in the host 
to achieve an immune tolerance to microbiota but retaining the ability to respond to invading pathogens. Pcrturbation of 
this balance by manipulation ofmicrobial communities in the host can lead to immune dysregulation and susceptibility to 
diseases. By studying the host in the absence of microbiota or with alteration of microbiota the complexity of microbial 
impact on the immune system can be resolved. Conversely, the study of microbiota in the absence of immune system 
factors can show how the immune system contributes to preservation of the hostmicrobiota balance. The absence of 
molecules involved in innate or adaptive immunity in knockout models can perturb the balance between host and 
microbiota further adding to more immune dysregulation. A better understanding of Microbiome-immune system 
interaction provides a new opportunity to identity biomarkcrs and drug targets. This will allow the development of new 
therapeutic agents for modulating the immune system to improve health with little or no toxicity. The study of interplay 
between host and microbiota has a promising role in the design of therapeutic interventions for immunopathological 
diseases arising from imbalanced host and microbiota interactions. 
Keywords: Adaptive and innate immunity, autoimmunity, helper T cells, immune regulation, immune system, microbial 
diversity, microbiome, probiotics. 
MICROBIOTA AND IMMUNE SYSTEM DIALOGUE 
In an evolutionary process over a long period of interactions 
between microbial agents and their hosts, microbes adapted 
themselves to host environment for a peaceful coexistence, 
mutual benefits, and symbiosis. The whole microbial population 
residing in a host, especially at mucosal surfaces such as 
gastrointestinal tract, gut microbiota, could have a big impact on 
shaping cellular and humoral immunity of the host to 
. - 
accomplish an immune tolerance to commensal bacteria, 
fulfilling the requirements of biological mutualism. On the other 
hand. i r i s  ola'sible that anv change in cellular and humoral - 
immunity can perturb the steady state balance of microbial 
populations in the gut and in turn, reshape the immune system 
into a new format. The study of mice, either kept in germ free 
conditions or being knocked out for specific genes of the 
immune system, has revealed the intricate complexity of the 
reciprocal interaction between mammalian host and normal 
bacterial flora. Specific bacterial phyla have a role in 
modulating adaptive immune responses and can influence the 
shift to specific T cell subsets [I 51. Conversely, the number of 
anaerobic commensal bacteria drastically increases in mice 
deficient for the activation induced cytidine deaminase (AID) 
gene due to a failure of the humoral immune response in 
restraining overgrowth of commensal bacteria [6]. 
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Reconstitution of germ free mice with one or a 
consortium of specific bacteria is a valuable tool to assess 
the impact of bacteria on immune system development. 
Colonization of germ free mice with gram negative 
Bacteroides fragilis [7 101 leads to expansion of IL-I0 
producing regulatory T cells (Tregs), mediated by binding of 
bacterial capsular polysaccharide antigen (PSA) to TLR2 [9]. 
Bacteroides fragilis releases PSA in outer membrane 
vesicles that could be recognized by TLR2 on dendritic cells 
11 11. Internalization of these vesicles induces toleroeenic IL- 
. . - 
10 producing dendritic cells that in turn drives the 
development of IL-I0 producing regulatory T cells [I 11. The 
induction of Tregs byB.  /?a& iCprimarily a r eqk imen t  
for efficient colonization of bacteria in a peaceful 
environment of the gut in a symbiotic host. Furthermore, 
PSA from B. fragilis is able to suppress antibacterial IL-17 
oroduction in the eut lamina orowria F81 for further provision 
- . . . .  
of friendly host environment and enhancement of its 
colonization, lmmunoreaulatorv effects of PSA on immune 
system are not restricted to the gut and they adjust the 
balance of ThtiTh2 subsets systemically [7]. G e m  free mice 
show a reduced IFN-7 to IL-4 cytokine ratio compared to 
conventional mice and colonization of mice with B. Jkagitis 
increases IFN-y up to a normal level observed in 
conventional mice [7]. In an experimental setting, 
colonization of mice with Bacleroides fragilis leads to 
protection from colitis development due to PSA-mediated 
expansion of IL-10 producing regulatory T cells and 
suppression of IL-17 producing cells 181. Capsular 
polysaccharide A (PSA) of Bacleroides fragilis can also 
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protect against central nervous system demyelinating 
disease, EAE, by induction of IL-10 producing regulatory T 
cells [12, 13]. These immunomodulatory features have also 
been reported for the other commensal bacterial species [1, 
14]. The homing of regulatory T cells to large intestine is 
mediated through GPR15 receptor that its expression is 
modulated by gut microbiota [15]. Conversely, colonization 
of bacterial species in the gut requires the presence of 
regulatory T cells and depletion of these cells or perturbation 
of the Treg to Th17 balance leads to less efficient 
colonization of Bacteroides fragilis in the gut [10]. 
INNATE IMMUNE RECEPTORS 
 Interaction of bacterial associated molecular patterns 
with innate immune receptors such as toll like receptors 
(TLR) or NOD family of intracellular signaling molecules 
(NLRs) in the gut is proposed as a plausible mechanistic link 
between microflora and immune system for the induction of 
tolerogenic response. Direct interaction of polysaccharide A 
from Bacteroides fragilis with TLR2 on the surface of 
dendritic cells or regulatory T cells provides immunologic 
tolerance for bacterial colonization in the gut mucosa [10, 
11]. Bacteroides fragilis lacking PSA are not able to restrain 
T helper 17 cell response that is a negative regulator of 
bacterial colonization [10]. Colonization of germ free mice 
with a consortium of eight enteric bacterial species, altered 
Schaedler flora (ASF), expands CD4+CD25+Foxp3+ Tregs 
in the colon through TLR signaling [14]. Nonetheless, this 
effect can occur even in the absence of TLRs. A mixture of 
clostridia species induces IL-10 producing Tregs in the 
colonic lamina propria of germ free mice that is independent 
from MyD88 signaling pathway [1]. The effect of MyD88 
pathway in microbiota-mediated modulation of immune 
response has been described by using MyD88 knockout mice 
[57]. To add another layer to the complexity of microbiome-
host interactions, a deficiency in TLR or MyD88 signaling 
pathway in mice by itself could alter the composition of gut 
microbiota that secondarily affects immune system. It has 
been argued that the composition of gut microbiota in TLR 
or MyD88 deficient mice might not be really different from 
wild type mice and the apparent observed differences are 
mainly due to different parental lineage and husbandry rather 
than genetic difference [16]. Different TLR receptors could 
have an activating or inhibiting function in one specific 
setting and blocking of the MyD88 pathway that is common 
to most of the TLR receptors that have opposing actions 
could lead to misleading interpretations. Absence of 
inflammasome signaling pathway molecules in NLR 
deficient mice leads to disrupted intestinal homeostasis of 
gut microbiota [17, 18]. 
MATURATION OF CELLULAR IMMUNE RESPONSE 
 Colonization of germ free mice with segmented 
filamentous bacteria (SFB) induces an IL-17 response in the 
gut lamina propria [5]. The induced Th17 cells are able to 
protect mice against an intestinal pathogen, Citrobacter 
rodentium [5], indicating that gut microbiota could empower 
host defense mechanisms against environmental pathogens 
or opportunistic pathogens. These Th17 biased cellular 
changes are not necessarily associated with the gut 
immunopathology because different subsets of Th17 have 
been proposed that differ markedly in pathogenic potential 
[19, 20]. Adoptive transfer of naturally occurring Th17 cells 
from the gut does not result in colitis development but rather 
have a regulatory function [21]. These cells express CTLA-4 
and CCR6 while pathogenic Th17 cells produce IL-17, IFN-
γ and TNF-α [21]. The impact of SFB in the gut is not 
restricted to induction of Th17 cells and the complexity of 
the overall balance of T cell responses should be considered 
for pathogenic or protective clinical outcome. Earlier reports 
indicated an induction of one specific T cell subset following 
colonization of germ free mice with specific bacteria [1, 4]. 
For example, germ free mice colonized with clostridial 
species clusters IV and XIVa promote regulatory T cell 
expansion [1, 2] while mice colonized with SFB promote 
Th17 cells [4]. However, the role of SFB in shaping immune 
response is much broader than mere induction of one 
specific subset and it contributes to full maturation of gut 
immune response [22] and induction of a wide range of T 
cell responses comprising of Th17, Th1, Th2 and Treg cells 
[23]. This might explain why SFB colonization is associated 
with protection in some experimental models of disease such 
as the NOD mouse model of type 1 diabetes [24, 25], while 
it is pathogenic in other experimental settings such as EAE 
and arthritis [26, 27]. One possible mechanism for a 
protective role of IL-17 in a mouse colitis model is through 
modulation of Th1 response [28]. Colitis is more severe in 
IL-17 deficient mice that are associated with unrestrained 
Th1 activity [28]. In an arthritis mouse model, segmented 
filamentous bacteria (SFB) lower the activation threshold for 
T cells encountering chronic antigenic exposure in gut 
draining lymphoid tissues, and thus promote differentiation 
of pathogenic Th1 cells and enhance the severity of an 
autoimmune response [3]. In sum, upregulation of both T 
helper and regulatory T cell subsets after colonization of 
germ free mice with SFB as a prototype of microbiota 
strongly suggests maturation of the whole cellular immune 
response rather than preferential expansion of one specific T 
cell subset in the gut. 
HUMORAL IMMUNE RESPONSE 
 In addition to cellular response, SFB has been reported to 
induce a strong IgA response [23, 29]. This could prevent 
overwhelming expansion of SFB or other commnensal 
bacteria in the gut to preserve intestinal homeostasis. An 
increased expansion of SFB in the small intestine of IgA 
deficient AID-/- mice has been reported [30]. The activation-
induced cytidine deaminase (AID) enzyme is required for 
immunoglobulin class switching and affinity maturation of 
antibodies in the germinal center of B cell follicles. High 
affinity IgA is essential for control of commensal species 
such as SFB and protection against pathogens such as 
Salmonella typhimurium [31]. Mouse IgA secreting plasma 
cells produce antimicrobial mediators such as tumor-necrosis 
factor-alpha (TNF-α) and inducible nitric oxide synthase 
(iNOS) in response to microbial stimulation. These cells are 
absent in germ free mice and colonization of germ free mice 
with microbiota restores the secretory IgA response [6, 32]. 
Deletion of TNF-α and iNOS in plasma cells leads to 
reduction in IgA production, concomitant change in the 
composition of gut microbiota, and perturbed intestinal 
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homeostasis [33]. Point mutation in the AID gene results in 
hyperplasia of germinal center B cells in gut-associated 
lymphoid tissues and expansion of microflora in the small 
intestine [34]. These findings indicate that somatic hyper-
mutation, affinity maturation, and secretory IgA responses 
have a critical role in the maintenance of intestinal homeo-
stasis and mucosal defense. 
REGULATION OF Th17 RESPONSE 
 Gut microbiota could also modulate the number and 
function of dendritic cells to eschew T cell response toward a 
specific T cell subset. The number of CX3CR1+ dendritic 
cells is reduced in germ free mice. This subset of dendritic 
cells preferentially supports Th1 and Th17 CD4+ T cell 
differentiation [35], in contrast to CD103+ DCs that 
preferentially induce differentiation of Foxp3+ regulatory T 
cells [36]. In general, the commensal bacteria in the gut have 
a significant impact on maturation of the gut immune system 
[37] and intestinal colonization contributes to combined 
effector and regulatory T cell responses. It is interesting that 
some bacteria such as SFB could depict the overall impact of 
whole microbiota on immunity in the gut [23]. Microbiota-
derived ATP activates purinergic receptors on dendritic cells 
to induce Th17 cells in lamina propria [38]. The percentage 
of Th17 cells in gut lamina propria depends on the presence 
of microbiota, therefore the level of Th17 cells are markedly 
low in germ free mice [4]. Differences in composition of gut 
microbiota in mice from different animal facilities 
contributed to the varied proportions of Th17 cells in lamina 
propria [4]. The severity of EAE in germ free mice is 
reduced as a result of lower levels of IL-17 and IFN-γ [27]. 
However colonization of mice with SFB leads to increased 
infiltration of Th17 cells in the central nervous system and 
exacerbation of disease [27]. In a mouse model of 
autoimmune arthritis, germ free mice show attenuation of 
disease accompanied with lower Th17 cell frequency [26], 
whereas SFB monocolonization in those mice leads to an 
increase in Th17 cell numbers in the lamina propria and 
exacerbation of disease [26]. Contrary to clinical 
manifestations in EAE and arthritis models [26, 27], the 
presence of SFB-induced lamina propria resident Th17 cells 
in NOD mice protect mice from diabetes [24]. This might 
occur as a result of the regulation of Th17 cells in the small 
intestine [39]. Migration of Th17 cells to the small intestine 
through a CCR6/CCL20 chemokine receptor/ligand interact-
ion leads to either deletion of these cells or acquisition of a 
regulatory IL-10 producing phenotype in the gut [39]. These 
Th17 cells express the IL-10 receptor and suppress 
pathogenic Th17 cells in gut via IL-10 signaling [40]. 
Commensal bacteria can induce expression of IL-25 (IL-
17E) in intestinal epithelial cells that inhibits production of 
IL-23, a major survival factor for Th17 cells, to restrain 
Th17 response [41]. 
INTESTINAL HOMEOSTASIS AND IMMUNE RESPONSES 
 Alteration of gut microbiota with diet, antibiotic 
treatment, or intestinal pathogens could predispose hosts to 
immunopathological disorders [42_44]. Interaction of dietary 
derived natural ligands for aryl hydrocarbon receptor (AhR) 
helps to maintain intestinal intraepithelial lymphocytes [42]. 
Disruption of this mechanism as a result of dietary changes 
compromises the epithelial integrity, increases immune 
response, and changes composition of gut microflora [42]. 
Commensal bacteria and their interaction with TLR receptors 
and MyD88 signaling pathway are required for protection 
from intestinal epithelial injury in experimental colitis [43]. 
Elimination of gut normal microflora with antibiotics 
contributes to high susceptibility of mice to experimental 
colitis induction with dextran sodium sulfate (DSS) [43]. An 
entropathogenic bacterium Salmonella enterica inhibits the 
growth of microbiota in the gut and subsequently 
predisposes mice to colitis development [44]. Alteration of 
the gut microbiome by antibiotics in humnas can lead to the 
development of pathogenic Clostridium difficile infection 
[45]. In germ free mice, invariant natural killer T (iNKT) 
cells in lamina propria contribute to inflammatory bowel 
disease and asthma. Colonization of germ free mice with 
conventional microbiota helps to normalize the number and 
function of iNKT cells and reduce the severity of the 
immunopathology [46]. 
MICROBIOME AND IMMUNE SYSTEM BASED DISEASES 
Infectious Diseases 
 Microbiota in the gut protect the host from environmental 
pathogens [47, 48] in a process called colonization resistance 
[49]. Germ-free animals are unable to eradicate Citrobacter 
rodentium. However, commensals in conventionally raised 
mice are able to outcompete C. rodentium growth [50]. In 
response to commensal bacteria, paneth cells in the crypts of 
intestinal epithelial layer produce antibacterial peptides, 
alpha-defensin or cryptdin, through a TLR dependant 
pathway [48] to combat invading microorganisms [47, 48]. 
Intestinal colonizatioin of germ free mice with Bacteroides 
thetaiotamicron induces expression of antibacterial peptides, 
RegIIIβ and RegIIIγ in paneth cells [51]. The antibacterial 
lectin RegIIIγ isolates microbiota in the gut from intestinal 
epithelial surface [52]. This MyD88 pathway dependent 
production of RegIIIγ protects the intestinal mucosa against 
bacterial invasion [53]. Colonization of gut with Bacteroides 
thetaiotaomicron and B. fragilis suppresses pathogen-medi-
ated colitis [8]. Tryptophan metabolites from Lactobacilli 
contribute to colonization resistance against Candida species 
by promoting IL-22 response in innate lymphoid cells in the 
gut [54]. 
Allergic Diseases 
 In developed countries, changes in human gut microflora 
as a result of a western style diet or consumption of 
antibiotics contribute to a higher incidence of atopy and 
allergic diseases [55]. A significant reduction in intestinal 
microbial species including Clostridium cluster IV, 
Faecalibacterium prausnitzii, Akkermansia muciniphila has 
been reported in atoptic children [56]. In an allergic disease 
mouse model, intestinal microbiota, particularly during early 
infancy, play a critical role in regulating immune responses 
to avoid atopy. In this respect, administration of antibiotics 
in neonatal mice changes the composition of the bacterial 
population and exacerbates experimental murine allergic 
asthma [57]. An inverse relation between Helicobacter 
pylori presence in human stomach and allergic asthma has 
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been proposed [58]. Eradication of Helicobacter pylori by 
antibiotics abolishes this protective effect [58]. 
Autoimmune Diseases 
Type 1 Diabetes 
 It is well known that there is a sex-based difference in 
susceptibility to autoimmune diseases with higher female to 
male incidence rate of disease [59]. Differences in gut 
microbial composition between two sexes play a major role 
in this sex bias and contribute to the differential testosterone 
levels in male and female NOD mice [60, 61]. Accordingly, 
germ free NOD mice lose the sex bias for diabetes incidence 
and both sexes show a similar rate of disease incidence [61]. 
Colonization of germ free NOD mice in early life with 
commensal bacteria increases testosterone levels 
accompanied by protection from diabetes development [61]. 
The difference in number and composition of microbiota 
between male and female mice occurs after puberty. 
Analysis of microbiota composition before and after 
adulthood demonstrates that male mice after puberty 
gradually show variation from initial bacterial flora whereas 
microbiota from female mice remain stable [61]. These 
alterations in microbial composition are associated with rise 
in male hormonal levels and conversely male NOD mice 
undergoing castration show a bacterial composition similar 
to female NOD mice [61]. This points to the critical role of 
male hormones in shaping gut microflora. Transfer of gut 
microbiota from adult male to young female NOD mice 
induces elevation of testosterone levels that is beneficial in 
reducing diabetes incidence [60]. Blocking of androgen 
receptors in recipient mice abolishes this protective effect 
[60] that points to the prime role of male hormone signaling 
in disease prevention. Whereas androgenic hormones protect 
mice from autoimmunity [62], castration of male mice 
increases disease susceptibility [63]. The altered microbiota 
and hormonal differences change the pathogenic potential of 
T cells so that adoptive transfer of T cells from manipulated 
NOD to NOD/SCID mice is no longer pathogenic in 
recipient mice [60]. The contribution of microbiota to the sex 
bias in susceptibility to autoimmune diseases might be 
beyond mere modulation of hormonal levels [61]. Thus, a 
two signal model proposed that both microbes and hormones 
in parallel or in series have a role in the development of 
autoimmune disease [61]. Hormones can change microbiota 
composition but not all observed changes in microbiota 
necessarily lead to change in diabetes incidence [61]. 
Colonization of germ free mice with gut microbiota 
increases testosterone levels, but there is no linear 
relationship between testosterone level and protection from 
diabetes [61]. The incidence of diabetes development in 
germ free MyD88-deficient NOD is high [64] and 
monocolonization of these mice with SFB leads to protection 
only in male mice that indicates both microbes and sex 
hormones are critical for protection [61]. In a contrasting 
report that indicates there is no evidence for the association 
of germ free status with an increased incidence of diabetes, 
monoclonization of female NOD mice with an aerobic spore 
forming bacteria, Bacillus cereus, reduces disease incidence 
[65]. In sum, sex hormones influence composition of gut 
microbiota and alternatively, gut microbiota change sex 
hormone levels. 
 Nonobese diabetic mice deficient for MyD88 signaling 
do not develop type 1 diabetes. However, germ free 
MyD88−/− NOD mice are highly susceptible to diabetes [64]. 
The composition of gut microbiota in MyD88-deficient 
NOD mice and wild type NOD mice is remarkably different 
[64]. It seems that the immune insult on islet cells occurs 
independently from MyD88 pathway for the interaction of 
gut microbiota with host cells. The other possibility would 
be that different TLRs have opposing effects in host-
microbiota interaction and disruption of the MyD88 
signaling pathway that is common for many TLRs masks the 
potential clinical phenotype. Arguing against these 
interpretations, the observed differences in microbiota 
between wild type and TLR or MyD88 deficient mice could 
be a mere reflection of different parental lineage of mice and 
not genetic differences [16]. 
 Microbial agents have a role in regulating IFN-γ levels 
[7] that could have a role in protection from type 1 diabetes. 
Disruption in IFN-γ signaling in NOD mice abolishes sex 
based differences in susceptibility for diabetes development 
[61]. NOD mice deficient for IFN-γ or IFN-γ receptor show 
similar incidence of T1D in both sexes [61]. Of note, the 
protection observed after immunotherapy with mycobacterial 
products [66_69] also depends on IFN-γ response [68] and 
administration of recombinant IFN-γ inhibits diabetes 
process in NOD mice [70]. High levels of IFN-γ and TNF-α 
cytokines following adjuvant immunotherapy could have a 
role in induction of apoptosis in diabetogenic T cells [67]. 
The mechanism of adjuvant effect is not restricted to IFN-γ 
regulation and all changes induced upon adjuvant admin-
istration might be primarily under influence of mycobacterial 
adjuvant-induced alterations in compostion of gut micro-
biota. Adjuvant immunotherapy leads to upregulation of 
RegII and RegIII genes in islet of NOD mice [69, 71]. This 
effect is associated with an increase in IL-22 levels and 
neutralization of IL-22 abolishes RegII and RegIII gene 
expression [72]. Mice with IL-22 deficiency demonstrate 
changes in gut microbiota compostion [73]. Thus, we 
speculate that mycobacterial adjuvant-induced IL-22 res-
ponse could go through an intermediary stage for induction 
of Reg family of antibacterial peptides from intestinal 
epithelial cells that consequently changes gut microbiota in 
NOD mice for protection from diabetes development. 
 Presence of SFB in the gastrointestinal tract of NOD 
mice is associated with protection from diabetes [24]. While 
SFB is associated with Th17 cells in NOD mice, no 
immunopathology is observed in these mice [24]. Th17 cells 
are not always pathogenic [19, 39]. Th17 polarized cells after 
mycobacterial adjuvant immunotherapy in NOD mice 
acquire a regulatory phenotype with increased IFN-γ, IL-17, 
IL-22 and IL-10 [74]. Th17 cells might not be a main source 
of pathogenic T cell as diabetes can happen even in the 
absence of IL-17A and IL-17F genes in NOD mice [75]. 
However, the colonic lamina propria of NOD mice show 
higher levels of Th17 cells and IL-23 mRNA that could be 
abolished with the use of an anti-diabetogenic diet [76]. In 
germ-free NOD mice, equal incidence of diabetes, high 
incidence of insulitis, increased numbers of Th17 and Th1 
cells, and diminished numbers of Tregs in mesenteric and 
pancreatic lymph nodes compared to conventional NOD 
mice have been reported [77]. In another diabetes model, 
distinct bacterial populations have been reported in the 
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diabetes resistant and diabetes susceptible Bio-Breeding 
(BB) rats. The protection from diabetes in this animal model 
is associated with Th17 response in the gut and draining 
mesenteric lymph nodes. Oral transfer of Lactobacillus 
johnsonii from diabetes-resistant BB rats to diabetes -prone 
BB rats conferred resistance to diabetes development [78]. 
Inflammatory Bowel Disease (IBD) 
 The human gut environment in a steady state shows a 
tolerant immune response to microbes residing in the gut. In 
this respect, an excessive derailed immune response to the 
gut microbiota might be the main feature of IBD. Intestinal 
microbiota could be protective against the development of 
inflammatory diseases and there are reports of alterations in 
gut microbial communities in patients with IBD [79, 80]. 
Elimination of gut flora in mice with antibiotics leads to 
higher susceptibility to experimentally induced colitis [43]. 
Presence of clostridia clusters IV and XIVa was associated 
with the presence of regulatory T cells in the gut lamina 
propria [1] and maintenance of these bacterial species is 
necessary for prevention of IBD. Intestinal microbiota 
convert dietary fiber into short-chain fatty acids (SCFAs) 
comprised of acetic, propionic, and butyric acids [81]. 
Interaction of these SCFAs with a G protein-coupled 
receptor, GPR43, on gut epithelial cells is necessary for 
dampening inflammatory responses in the gut [81], as mice 
deficient for GPR43 receptor demonstrate exacerbated 
intestinal inflammation and colitis. These SCFAs modulate 
regulatory T cell responses in terms of number and function 
in the gut and protect against colitis [82_84]. These three 
metabolites demonstrate distinct modes of action [82]. 
Butyrate and propionate exclusively expand regulatory T 
cells generated outside the thymus [82]. While acetate just 
promotes accumulation of regulatory T cells in colon, 
butyrate induces de novo generation of regulatory T cells in 
the periphery [82]. These metabolites are known as histone 
deacetylase (HDAC) inhibitors that regulate transcription of 
Foxp3 gene epigenetically to confer more stability to Foxp3 
function in regulatory T cells [82, 83]. Regulatory T cells 
that are induced in periphery do not express Helios and 
neurophilin 1, markers of thymic derived Tregs [83]. T cells 
in the colon express high levels of GPR43 receptor in 
response to microbiota and receptor engagement contributes 
to homeostasis of colonic regulatory T cells and their 
enhanced suppressive activity for prevention of colitis 
development [84]. Butyrate also modulates the immune 
response of macrophages in the gut lamina propria and 
reduces the production of proinflammatory mediators, IL-6, 
IL-12 and nitric oxide (NO) [85]. The CX3CR1hiCD103- 
intestinal macrophages are hyporesponsive to the gut 
microbiota [85]. In comparison to regulatory T cells, the 
anti-inflammatory effect of butyrate on lamina propria 
macrophages is not mediated by GPR43 receptor but it acts 
as a histone deacetylase (HDAC) inhibitor [85]. A feature of 
human ulcerative colitis is a change in normal gut microbiota 
such as Bifidobacterium and Bacteriodes that lead to reduced 
production of SCFAs metabolites. Accordingly, germ free 
mice are not able to produce SCFAs and therefore, are more 
susceptible to inflammatory responses [81]. 
 Interaction of TLRs with commensal bacteria in the gut 
helps to maintain intestinal epithelial homeostasis [43]. 
Disruption of this protective mechanism with the use of 
broad spectrum antibiotics in mice and consequent changes 
in the gut microbiota could lead to higher susceptibility to 
colitis induction in animal models [43]. Deficiency in the 
inflammasome pathway also leads to increased risk of 
experimental colitis that is accompanied with changes in 
commensal microbiota [86, 87]. Deficiency of NLRP6 in 
mouse colonic epithelial cells results in expansion of the 
bacterial phyla Bacteroidetes (Prevotellaceae) and TM7 and 
high susceptibility to experimental colitis that is transferable 
to normal wild type mice through sharing of gut microbiota 
[18]. 
 Commensal bacteria such as Bacteroides species could 
induce disease only in IBD susceptible hosts that are 
deficient for IL-10 and TGF-β cytokines and pre-treated with 
antibiotics [88]. Antibiotics could be used to reduce the 
burden of commensal bacteria for the treatment of IBD [89]. 
Spontaneous colitis in IL-10 deficient mice could be 
prevented with the disruption of the MyD88 signaling 
pathway [90], which indicates that IL-10 regulates 
commensal bacteria driven colitis through the MyD88 
pathway. The altered microbiota profile seen in IBD does not 
necessarily reflect the etiology of the disease and there might 
be a complex interplay between susceptibility genes and 
microbiota for disease progression. The extent of 
colonization of Bacteroides species in both IBD susceptible 
and non-susceptible stains of mice is the same [88]. Despite 
preponderance of Enterobacteriaceae in the intestine of the 
IBD afflicted mice, transfer of these bacteria to IBD 
susceptible mice does not induce disease [88]. 
 In a TRUC mouse model, RAG deficient mice lacking 
the T-bet transcription factor, spontaneous colitis devolops 
that resembles human ulcerative colitis [91]. Gut microbiota 
in these mice are different from wild type mice and transfer 
of microbiota to wild type mice results in colitis induction 
[91, 92]. T-bet regulates production of TNF-α in dendritic 
cells to prevent pro-inflammatory response to gut microbiota 
and thus excessive production of TNF-α by colonic dendritic 
cells in the TRUC colitis model causes tissue injury in the 
colon [91]. 
 IL-22 from different cellular sources such as innate 
lymphoid cells, Th17 cells and natural killer cells can have a 
protective role in inflammatory bowel disease [73, 93, 94]. 
IL-22 induces the expression of Reg family of antimicrobial 
peptides, RegIIIβ and RegIIIγ in colonic epithelial cells [95]. 
In the absence of antibacterial effects of IL-22, commensal 
bacteria can be overwhemingly expanded. IL-22 deficient 
mice have an altered composition of gut microbiota and 
demonstrate more severe colitis in an experimental mouse 
model [73]. Of note, the Lactobacillacae family of normal 
gut microflora is reduced in these mice [73]. Gut microbiota 
could be exchanged between co-housed mice because of 
copraphagia in mice. Transfer of the altered microbiota of 
IL-22 deficient mice to wild type mice during co-housing 
leads to colitis development in wild type mice [73]. It is 
likely that altered flora in turn have a negative feedback on 
IL-23-IL-22 pathway. In contrast to its role in experimental 
colitis, IL-22 deficient mice are not susceptible to 
spontaneous colitis which indicates that IL-22 is not a sole 
factor for maintaining intestinal homestasis [94]. However, 
IL-22 from NK cells and CD4+ T cells is protective in 
experimental colitis induced by DSS or by transfer of 
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CD4+CD45RBhi cells to RAG deficient mice [94]. In a 
steady state, intestinal IL-22 producing NKp46+ cells are 
generated in response to commensal bacteria [96]. A dual 
protective or pathogenic role for IL-22 in different disease 
contexts has been reported. The cellular source of IL-22 or 
accompanying other cytokines in those cells might dictate 
the protective or pathogenic role of IL-22 in various disease 
backgrounds. 
Multiple Sclerosis and EAE Mouse Model 
 Oral administration of antibiotics can modify the 
composition of gut microbiota to protect mice against 
experimental autoimmune encephalomyelitis (EAE), an 
experimental model of multiple sclerosis in humans [97]. 
This protective effect is associated with a reduced production 
of inflammatory cytokines, an increased IL-10 producing 
Foxp3+ regulatory T cell response [97], and an enhanced IL-
10 producing regulatory CD5+ B cell response [98]. A 
probiotic mixture of lactobacilli also induces regulatory T 
cells that leads to protection from EAE [99]. Oral treatment 
with purified PSA antigen derived from human commensal 
microbiota, Bacteroides fregilis protects mice against EAE 
by enhancing CD103+ dendritic cells for induction of 
regulatory T cells in the gut, mesenteric, and cervical 
lymphoid nodes [12, 13]. Similar to a NOD mouse model, 
administration of mycobacyterial adjuvant has a protective 
role in an EAE model [100]. 
Rheumatoid Arthritis 
 Analysis of gut microbiota from patients with recent-
onset rheumatoid arthritis (RA) indicates that there is a 
strong association of the disease with the presense of 
Prevotella copri and reduction in Bacteroides and other 
beneficial gut bacteria [101]. Accordingly, the prevalance of 
P. copri in patients treated for rheumatoid arthrits is similar 
to healthy individuals [101]. Mice that are genetically prone 
to arthritis and colonized with P. copri are more susceptible 
to the experimental induction of colits with DSS [101]. In 
animal mouse models of arthritis, germ free mice do not 
develop arthritis but upon colonization with specific gut 
microbiota demonstrate joint inflammmation [26, 102]. 
Colonization of germ free mice with segmented 
filammentous bacteria, SFB, is associated with an elevated 
Th17 cell response and exacerbation of arthritis [26]. Mice 
deficient for an IL-1 receptor antagonist (IL-1ra) develop 
arthritis spontaneously [102]. While these mice in germ free 
status do not develop arthritis, colonization with a specific 
gut microbiota, Lactobacillus bifidus results in rapid onset of 
arthrits [102]. Differential engagement of Toll like receptors 
by normal microflora impacts the pathogenesis of arthritis in 
this mouse model. Deficiency for TLR2 in these mice 
exacerbates the disease, lowers regualtory T cells and 
enhances Th1 response, whereas deficiency in TLR4 protects 
from arthritis and attenuates Th17 response [102]. There 
might be a connection between the genetic background of 
host and the compostion of gut microbiota. Analysis of gut 
microbiome in HLA-DR transgenic mice carrying either the 
RA susceptible or resistant HLA-DR alleles indicates a 
differential pattern with the dominance of Clostridium 
species in RA susceptible transgenic mice [103]. 
MICROBIOTA AND HEALTH 
 The whole bacterial genome from the human gut has 
been characterized with metagenomic sequencing [104_106]. 
Analysis of microbiota that could be grown in cultures in 
vitro indicates that healthy people have similar bacterial 
species in gut [104]. However, culture independent 
sequencing shows variations in bacterial species between 
human populations [104]. Factors such as genetic 
background, age, diet and consumption of antibiotiotics in 
host together with environmental agents contribute to 
variability in the composition of gut microbiota [104]. 
Monozygotic and dizygotic twins have similar microbiota 
which indicates that environmental factors are more 
important in shaping individual variations [104]. 
Nutrition and Obesity 
 Diet can change the composition of gut microbiota to 
promote obesity. Germ free mice are resistant to obesity that 
is induced by a western style high fat diet [107]. Transfer of 
microbiota from mice with diet-induced obesity to germ-free 
recipient mice promotes fat deposition [108]. Lymphotoxin β 
receptor (LTβR) regulates the microbiota in the gut to induce 
obesity after intake of high fat diet [109], which indicates 
that both genetic background of host and composition of 
microbiota are involved in obesity. A hallmark of diet-
induced obesity is the loss of diversity in microbial 
communities and lower frequency of SFB in the gut [109]. 
Diet-induced obesity in mice is transferable from susceptible 
to resistant mice after co-housing of two groups of mice 
[109]. A High fat diet induces a LTβR dependent activation 
of the IL-23-IL-22 cytokine pathway in innate lymphoid 
cells to produce IL-22 [109], which is a key player in the 
process of diet–induced obesity and reduction of SFB 
colonization [109]. IL-22 driven production of the 
antibacterial peptide, RegIIIγ, limits the outgrowth of SFB in 
the gut [109]. Study of fecal microbial communities in twin 
individuals, being either lean or obese, has shown phylum-
level differences in the gut microbiota [110]. Long-term diet 
modulates composition of gut microbiome so that diets rich 
in protein and fat are associated with presence of Bacteroides 
species whereas diets rich in carbohydrates are associated 
with Prevotella species [111]. Analysis of gut microbiota in 
two groups of children from Europe and Africa showed that 
there is a higher number of Bacteroidetes phylum (Prevotella 
and Xilanibacter species) and lower number of Firmicutes 
phylum in African children compared with the European 
children [112]. The diet of the African children was low in 
fat and protein and rich in carbohydrate. The presence of 
specific bacterial communities in these children resulted in 
more production of short chain fatty acids (SCFA) [112]. 
Obesity is associated with a decrease in Bacteroidetes 
phylum and an increase in Firmicutes phylum in the gut 
[113]. Colonization of germ-free mice with microbiota from 
genetically leptin-deficient obese mice results in an increase 
in total body fat in recipient mice [113, 114]. Microbiota in 
obese animals are adapted to more efficient energy 
harvesting and higher absorption of nutrients in the diet 
[114]. Diets enriched with saturated fat induce dysbiosis in 
the gut, which leads to a high incidence of colitis in IL-10 
deficient mice [115]. Dietary derived natural ligands for aryl 
hydrocarbon receptor (AhR) help maintain intestinal 
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intraepithelial lymphocytes and administration of AhR 
ligands promotes expansion of regulatory T cells [116]. 
Disruption of this pathway due to changes in diet alters the 
composition of gut microflora and local immune response 
[42]. In NOD mice, gluten free diet changes microbial 
communities in the gut and lowers the incidence of diabetes 
[117]. NOD mice that receive acidified rather than neutral 
drinking water show an altered compostion of gut microbiota 
that is associated with more suceptiblity to the development 
of insulitis and hyperglycemia [118]. Diet in the long run has 
an influence on the balance of major bacterial phyla by 
changing the ratio of Bacteroides to Firmicutes in the gut 
[108]. 
 Comparative analysis of germ free and conventional mice 
has revealed a profound effect of the gut microbiome on amino 
acid metabolites [119]. Deficiency in dietary tryptophan 
changes intestinal microbial composition [120]. Metabolites 
derived from tryptophan metabolism by indolamine dioxy-
genase (IDO) are involved in the generation of regulatory T 
cells via the aryl hydrocarbon receptor pathway [54]. Trypto-
phan metabolites from microbiota such as Lactobacilli are 
also involved in intestinal homeostasis and colonization 
resistance [54]. These microbiota-derived tryptophan meta-
bolites promote IL-22 responses in innate lymphoid cells in 
the gut [54]. Tryptophan deficiency leads to dysregulation in 
the gut immune response, an altered profile of gut microbiota 
and predisposition to opportunistic infections. The pathway 
of Tryptophan metabolites-AhR-IL-22 plays a critical role in 
resistance against colonization by Candida species at muco-
sal surfaces [54]. IL-22 from innate immune cells can regu-
late Th17 cell responses. Reduced levels of IL-22 in innate 
immune cells in AhR deficient mice result in the expansion 
of SFB in the gut and subsequent expansion of Th17 cells in 
the intestine leading to colitis development [121]. 
THERAPEUTIC INTERVENTIONS, PROBIOTICS 
AND MICROBIOME 
 Probiotics are designed to restore gut microbial 
composition to normal state and adjust the immune system. 
Suppression of effector response and induction of regulatory 
T cells has been reported with the consumption of probiotics 
[122]. Colonization of mice by Clostridium strains promotes 
regulatory T cell response in the gut [1]. Oral administration 
of Clostridium species during the early life in mice is benefi-
cial in preventing colitis [1]. Consumption of Bifidobact-
erium infantis in mice leads to an increase in the number of 
regulatory T cells and protection against Salmonella typhi-
murium infection [123]. Bifidobacteria produce acetate that 
improves intestinal defense against enterohaemorrhagic Esc-
herichia coli [124]. Also, Lactobacillus rhamnosus and Bifi-
dobacterium infantis have a protective effect in the 
prevention of colitis development [125]. Perturbation of the 
balance between major bacterial phyla in the gut microbiota, 
more specifically, a decreased level of a member of Firm-
icutes, Faecalibacterium prausnitzii, is associated with a 
higher risk of Crohn’s disease [126]. Oral administration of 
anti-inflammatory commensal F. prausnitzii reduces the 
severity of experimental colitis by correcting the dysbiosis 
[126]. Fecal microbiota transplantation has shown to be 
promising in the treatment of Clostridium difficile infections 
[127]. Fecal transfer from SFB positive donors suppresses 
type 1 diabetes in recipient NOD mice [118]. 
 In conclusion, the rapidly growing knowledge of micro-
biome-host interactions has bought up new avenues in under-
standing immunopathological basis of disease and gives a 
promising outlook in conceiving novel therapeutic protocols 
in health and prevention of diseases. 
LIST OF ABBREVIATIONS 
AID = Activation Induced Cytidine Deaminase 
Tregs = Regulatory T cells 
PSA = Polysaccharide Antigen 
TLR = Toll Like Receptor 
NLR = NOD Like Receptor 
ASF = Altered Schaedler Flora 
SFB = Segmented Filamentous Bacteria 
TNF-α = Tumor Necrosis Factor alpha 
iNOS = Inducible Nitric Oxide Synthase 
AhR = Aryl hydrocarbon Receptor 
iNKT cells = Invariant Natural Killer T cells 
NOD mice = Non Obese Diabetic mice 
SCID mice = Severe Combined Immunodeficiency mice 
IBD = Inflammatory Bowel Disease 
HDAC = Histone Deacetylase 
DSS = Dextran Sulfate Sodium 
EAE = Experimental Autoimmune Encephalomyelitis 
RA = Rheumatoid Arthritis 
LTβR = Lymphotoxin β Receptor 
IDO = Indolamine Dioxygenase 
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